Atricure Inc. buy UBS Group AG
Start price
18.02.26
/
50%
€27.40
Target price
18.02.27
€46.43
Performance (%)
48.91%
Price
08:05
?
Summary
This prediction is currently active. With a performance of 48.91% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 18.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | 5.978% | 5.978% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) was given a new $55.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

